Bapotulimab

Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2) . Bapotulimab has antitumor and immunosuppressive effects[1].

Product Specifications

CAS Number

[2359413-58-2]

Product Name Alternative

BAY-1905254

UNSPSC

12352203

Target

Others

Type

Inhibitory Antibodies

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/bapotulimab.html

Purity

95.00

Solubility

10 mM in DMSO

Smiles

[Bapotulimab]

Molecular Weight

(144.98 kDa)

References & Citations

[1]Julia Huetter, et al. Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2) . Cancer Immunol Res. 2020 Jul;8 (7) :895-911.